Here are five notes:
1. The series highlights the council’s members making an impact on the life sciences industry.
2. The Massachusetts Biotechnology Council is an association of more than 650 biotechnology companies, universities, academic institutions and others.
3. InVivo Therapeutics is a biomaterials and biotechnology company with focusing on the treatment of spinal cord injuries.
4. The company’s biodegradable Neuro-Spinal Scaffold, designed for patients with acute spinal cord injury, is currently being studied in an investigational device exemption clinical study.
5. Mount Sinai was recently named a new clinical site for the Neuro-Spinal Scaffold trial.
More articles on devices:
Q2 financials: 150 things to know about NuVasive, Stryker, J&J Orthopedics & more
Magec rod lines up with natural growth of children with scoliosis: 5 things to know
Nextremity Solutions receives 7 patents: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
